Mathilde Marchand

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 293 citations · Full text

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting

Kari M. Morrissey, Mathilde Marchand, Hina Patel et al. · Cancer Chemotherapy and Pharmacology · 2019 · 86 citations · Full text

Population pharmacokinetics of bevacizumab in cancer patients with external validation

Kelong Han, Thomas Peyret, Mathilde Marchand et al. · Cancer Chemotherapy and Pharmacology · 2016 · 71 citations · Full text

Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework

Phyllis Chan, Mathilde Marchand, Kenta Yoshida et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 32 citations · Full text